Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study.

Avery Feit Moshe Gordon Tharun T Alamuri Wei Hou William Beauregard Mitchell Deepa Manwani Timothy Q Duong

Published in: European journal of haematology (2023)

SCD patients with SARS-CoV-2 infection incurred no additional risk of worse long-term outcomes compared to matched controls of SCD patients not infected by SARS-CoV-2.

Keyphrases

sickle cell disease
sars cov
healthcare
end stage renal disease
ejection fraction
newly diagnosed
respiratory syndrome coronavirus
chronic kidney disease
peritoneal dialysis
patient reported outcomes